TELA Bio's market cap is currently ―. The company's EPS TTM is $-2.065; its P/E ratio is -2.30; TELA Bio is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 17.00M	$ 15.05M	$ 14.49M	$ 11.91M	$ 11.62M
Gross Profit	$ 11.72M	$ 10.48M	$ 10.30M	$ 11.91M	$ 8.18M
EBIT	$ -11.56M	$ -9.62M	$ -9.49M	$ -10.78M	$ 4.77M
EBITDA	$ -11.41M	-	$ -9.28M	$ -10.69M	$ -1.61M
Net Income Common Stockholders	$ -12.89M	$ -10.96M	$ -10.79M	$ -12.03M	$ -9.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 46.73M	$ 58.20M	$ 65.27M	$ 30.12M	$ 42.02M
Total Assets	$ 78.05M	$ 87.32M	$ 94.39M	$ 58.79M	$ 67.86M
Total Debt	$ 40.52M	$ 40.36M	$ 40.21M	$ 40.06M	$ 39.92M
Net Debt	$ -6.21M	$ -17.84M	$ -25.05M	$ 9.94M	$ -2.10M
Total Liabilities	$ 59.17M	$ 56.77M	$ 54.38M	$ 55.65M	$ 53.55M
Stockholders Equity	$ 18.88M	$ 30.55M	$ 40.05M	$ 3.14M	$ 14.30M
Cash Flow	-
Free Cash Flow	$ -11.24M	-	$ -11.42M	$ -11.69M	$ -12.03M
Operating Cash Flow	$ -11.05M	$ -6.97M	$ -11.26M	$ -11.57M	$ -10.98M
Investing Cash Flow	$ -193.00K	$ -134.00K	$ -157.00K	$ -115.00K	$ -1.05M
Financing Cash Flow	$ 22.00K	$ 71.00K	$ 46.41M	$ -235.00K	$ -219.00K

Currency in USD

TELA Bio Earnings and Revenue History

Income Statement >

TELA Bio Debt to Assets

Balance Sheet >

TELA Bio Cash Flow

Cash Flow >

TELA Bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing